These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34340862)

  • 1. Effective use of weight-based enoxaparin for deep vein thrombosis chemoprophylaxis in patients with traumatic brain injury.
    Taylor A; Martinez-Quinones P; Huang E; Robinson T; White CQ
    Am J Surg; 2022 Jan; 223(1):146-150. PubMed ID: 34340862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Anti-Xa Assay-Guided Low Molecular Weight Heparin Chemoprophylaxis Is Safe in Adult Patients with Acute Traumatic Brain Injury.
    Rodier SG; Kim M; Moore S; Frangos SG; Tandon M; Klein MJ; Berry CD; Huang PP; DiMaggio CJ; Bukur M
    Am Surg; 2020 Apr; 86(4):369-376. PubMed ID: 32391762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of early thromboembolism chemoprophylaxis after intracranial hemorrhage from traumatic brain injury.
    Farooqui A; Hiser B; Barnes SL; Litofsky NS
    J Neurosurg; 2013 Dec; 119(6):1576-82. PubMed ID: 24053504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creatinine clearance predicts the goal enoxaparin dose in traumatic brain injury.
    Park G; Dhillon NK; Fierro NM; Drevets P; Stupinski J; Ley EJ
    J Trauma Acute Care Surg; 2024 Feb; 96(2):270-275. PubMed ID: 37335174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Goal directed enoxaparin dosing provides superior chemoprophylaxis against deep vein thrombosis.
    Kopelman TR; Walters JW; Bogert JN; Basharat U; Pieri PG; Davis KM; Quan AN; Vail SJ; Pressman MA
    Injury; 2017 May; 48(5):1088-1092. PubMed ID: 28108019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early venous thromboembolism chemoprophylaxis in combat-related penetrating brain injury.
    Meyer RM; Larkin MB; Szuflita NS; Neal CJ; Tomlin JM; Armonda RA; Bailey JA; Bell RS
    J Neurosurg; 2017 Apr; 126(4):1047-1055. PubMed ID: 27315028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing for deep vein thrombosis chemoprophylaxis in traumatic brain injury: an evidence-based review.
    Abdel-Aziz H; Dunham CM; Malik RJ; Hileman BM
    Crit Care; 2015 Mar; 19(1):96. PubMed ID: 25887600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achievement of goal anti-Xa activity with weight-based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients.
    Taylor A; Huang E; Waller J; White C; Martinez-Quinones P; Robinson T
    Pharmacotherapy; 2021 Jun; 41(6):508-514. PubMed ID: 33864688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Xa guided enoxaparin dose adjustment improves pharmacologic deep venous thrombosis prophylaxis in burn patients.
    Cronin BJ; Godat LN; Berndtson AE; Pham A; Kolan S; Box K; Lee JG; Costantini TW
    Burns; 2019 Jun; 45(4):818-824. PubMed ID: 30827851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Chemoprophylaxis Against Venous Thromboembolism in Patients With Traumatic Brain Injury.
    Rivas L; Vella M; Ju T; Fernandez-Moure JS; Sparks A; Seamon MJ; Sarani B
    Am Surg; 2022 Feb; 88(2):187-193. PubMed ID: 33502231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of Weight-Based Prophylactic Enoxaparin Dosing in Critically Ill Trauma Patients: Adequacy of AntiXa Levels Is Improved.
    Nunez JM; Becher RD; Rebo GJ; Farrah JP; Borgerding EM; Stirparo JJ; Lauer C; Kilgo P; Miller PR
    Am Surg; 2015 Jun; 81(6):605-9. PubMed ID: 26031274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing of Pharmacologic Venous Thromboembolism Prophylaxis in Severe Traumatic Brain Injury: A Propensity-Matched Cohort Study.
    Byrne JP; Mason SA; Gomez D; Hoeft C; Subacius H; Xiong W; Neal M; Pirouzmand F; Nathens AB
    J Am Coll Surg; 2016 Oct; 223(4):621-631.e5. PubMed ID: 27453296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early venous thromboembolism prophylaxis in patients with trauma intracranial hemorrhage: Analysis of the prospective multicenter Consortium of Leaders in Traumatic Thromboembolism study.
    Wu YT; Chien CY; Matsushima K; Schellenberg M; Inaba K; Moore EE; Sauaia A; Knudson MM; Martin MJ;
    J Trauma Acute Care Surg; 2023 Nov; 95(5):649-656. PubMed ID: 37314427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
    Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
    Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical venous thromboembolism prophylaxis in neurosurgical patients: an updated systematic review and meta-analysis.
    Khan NR; Patel PG; Sharpe JP; Lee SL; Sorenson J
    J Neurosurg; 2018 Oct; 129(4):906-915. PubMed ID: 29192859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis.
    Reiff DA; Haricharan RN; Bullington NM; Griffin RL; McGwin G; Rue LW
    J Trauma; 2009 May; 66(5):1436-40. PubMed ID: 19430251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold Medal Forum Winner. Unfractionated heparin three times a day versus enoxaparin in the prevention of deep vein thrombosis in trauma patients.
    Arnold JD; Dart BW; Barker DE; Maxwell RA; Burkholder HC; Mejia VA; Smith PW; Longley JM
    Am Surg; 2010 Jun; 76(6):563-70. PubMed ID: 20583509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.